Cerenome, Inc.
CNSY
$2.49
-$0.21-7.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -70.43% | -2.93% | -3.19% | -4.05% | 8.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -70.43% | -2.93% | -3.19% | -4.05% | 8.68% |
| Cost of Revenue | 242.30% | 63.15% | 34.54% | -14.77% | -55.07% |
| Gross Profit | -2,776.39% | -163.56% | -103.36% | 25.89% | 109.64% |
| SG&A Expenses | 209.33% | 86.05% | 33.33% | 43.64% | -23.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 223.36% | 77.30% | 33.83% | 11.87% | -41.16% |
| Operating Income | -488.88% | -101.33% | -47.23% | -17.98% | 58.40% |
| Income Before Tax | -274.84% | 60.08% | -46.37% | -53.90% | 275.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -274.84% | 60.08% | -46.37% | -53.90% | 275.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -274.84% | 60.08% | -46.37% | -53.90% | 275.20% |
| EBIT | -488.88% | -101.33% | -47.23% | -17.98% | 58.40% |
| EBITDA | -510.54% | -107.17% | -57.57% | -22.36% | 58.58% |
| EPS Basic | -312.16% | 99.86% | 91.64% | 88.75% | 105.44% |
| Normalized Basic EPS | -149.05% | 99.89% | 91.64% | 88.75% | 123.54% |
| EPS Diluted | -701.84% | 99.86% | 91.53% | 88.87% | 99.08% |
| Normalized Diluted EPS | -312.03% | 99.89% | 91.64% | 88.75% | 109.00% |
| Average Basic Shares Outstanding | 256.42% | 36,416.48% | 1,650.57% | 1,267.66% | 644.46% |
| Average Diluted Shares Outstanding | -17.54% | 36,416.48% | 1,650.57% | 1,267.66% | 1,846.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |